Literature DB >> 21963565

P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.

Tolga Eichhorn1, Thomas Efferth.   

Abstract

P-glycoprotein belongs to the family of ATP-binding cassette (ABC) transporters. It functions in cellular detoxification, pumping a wide range of xenobiotic compounds, including anticancer drugs out of the cell. In cancerous cells, P-glycoprotein confers resistance to a broad spectrum of anticancer agents, a phenomenon termed multidrug resistance. An attractive strategy for overcoming multidrug resistance is to block the transport function of P-glycoprotein and thus increase intracellular concentrations of anticancer drugs to lethal levels. Efforts to identify P-glycoprotein inhibitors have led to numerous candidates, none of which have passed clinical trials with cancer patients due to their high toxicity. The search for naturally inhibitory products from traditional Chinese medicine may be more promising because natural products are frequently less toxic than chemically synthesized substances. In this review, we give an overview of molecular and clinical aspects of P-glycoprotein and multidrug resistance in the context of cancer as well as Chinese herbs and phytochemicals showing inhibitory activity towards P-glycoprotein.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963565     DOI: 10.1016/j.jep.2011.08.053

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  27 in total

Review 1.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

2.  Efficacy of traditional Chinese medicine in treating cancer.

Authors:  Jiao Nie; Changlin Zhao; L I Deng; Jia Chen; Bin Yu; Xianlin Wu; Peng Pang; Xiaoyin Chen
Journal:  Biomed Rep       Date:  2015-11-05

3.  SH003 enhances paclitaxel chemosensitivity in MCF-7/PAX breast cancer cells through inhibition of MDR1 activity.

Authors:  Hyeong Sim Choi; Sung-Gook Cho; Min Kyoung Kim; Hee Jae Lee; Seung Hee Moon; Hee Jae Jang; Seong-Gyu Ko
Journal:  Mol Cell Biochem       Date:  2016-11-16       Impact factor: 3.396

Review 4.  Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines.

Authors:  Ga-Young Lee; Jin-Seok Lee; Chang-Gue Son; Nam-Hun Lee
Journal:  Chin J Integr Med       Date:  2020-08-01       Impact factor: 1.978

5.  Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells.

Authors:  Victor Kuete; Louis P Sandjo; Doriane E Djeussi; Maen Zeino; Guy M N Kwamou; Bonaventure Ngadjui; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-07-19       Impact factor: 3.850

Review 6.  Natural Products That Target Cancer Stem Cells.

Authors:  Jim Moselhy; Sowmyalakshmi Srinivasan; Murali K Ankem; Chendil Damodaran
Journal:  Anticancer Res       Date:  2015-11       Impact factor: 2.480

Review 7.  Transport processes of radiopharmaceuticals and -modulators.

Authors:  Thomas Efferth; Peter Langguth
Journal:  Radiat Oncol       Date:  2011-06-06       Impact factor: 3.481

8.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

Review 9.  Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites.

Authors:  Mahmoud Zaki El-Readi; Ahmed M Al-Abd; Mohammad A Althubiti; Riyad A Almaimani; Hiba Saeed Al-Amoodi; Mohamed Lotfy Ashour; Michael Wink; Safaa Yehia Eid
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

10.  Chemotherapy and dietary phytochemical agents.

Authors:  Katrin Sak
Journal:  Chemother Res Pract       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.